Failure of a Single Surgical Debridement in Septic Arthritis of the Native Hip
1 other identifier
observational
150
1 country
1
Brief Summary
Septic arthritis of the native hip poses significant diagnostic and therapeutic challenges as it is considered an orthopedic emergency requiring urgent surgery. Inadequate or delayed treatment is disastrous, resulting in irreversible destruction of the joint. Initial treatment usually comprises of arthroscopic or open debridement. According to literature 25-38% of first debridement fail, requiring a second or third intervention or even a staged procedure with femoral head resection and a temporary antibiotic-loaded cement spacer. Understanding who will succeed and who will fail after a single surgical debridement of a septic hip joint could improve shared decision-making and could help decide which patient would benefit from resection arthroplasty straight away. In order to gain more insight in clinical factors associated with failure of a single surgical debridement in septic arthritis of the native hip, a retrospective cohort study will be conducted. There are no detailed guidelines for the treatment of septic arthritis of the native hip. Therefore, treatment today is similar to treatment 10 years ago (i.e. the treating surgeon does what he thinks is best for the patient). This lack of a structured approach is the reason for this retrospective study and we aim to come up with principles to guide treatment of future patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 26, 2021
CompletedFirst Submitted
Initial submission to the registry
January 29, 2021
CompletedFirst Posted
Study publicly available on registry
February 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJuly 3, 2024
July 1, 2024
4.8 years
January 29, 2021
July 2, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical factors associated with failure of a single surgical debridement
A retrospective data registry containing clinical data of patients with septic arthritis of the native hip will be constructed. This data registry will contain a sizable amount of clinico-pathological features collected from the electronic patient registry. Subsequently, a retrospective cohort study will be conducted in order to establish associations between certain clinical factors and the likelihood of failure of the initial surgical debridement.
Through study completion, an average of 1 year
Secondary Outcomes (6)
Population of patients who would benefit from a staged procedure
Through study completion, an average of 1 year
Prevalence of failure of initial debridement
Through study completion, an average of 1 year
Prevalence of staged procedure
Through study completion, an average of 1 year
Mortality
Through study completion, an average of 1 year
Recurrence
Through study completion, an average of 1 year
- +1 more secondary outcomes
Study Arms (1)
Patients with septic arthritis of the native hip
Interventions
To describe the clinical factors associated with failure of a single surgical debridement in patients with septic arthritis of the native hip.
Eligibility Criteria
Patients with septic arthritis of the native hip treated at UZ Leuven in the last decade
You may qualify if:
- All microbiology reports for cases of septic arthritis of the native hip joint concerning synovial fluid or solid tissue cultures obtained from arthrocentesis/debridement of the hip, collected from January 1st 2010 to January 1st 2020
- Patients are at least 18 years of age
- Cases with positive cultures in patients of which the initial diagnosis, treatment and follow-up was conducted at UZ Leuven Gasthuisberg
You may not qualify if:
- \- History of arthroplasty of the hip in the affected joint
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UZ Leuven
Leuven, 3000, Belgium
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 29, 2021
First Posted
February 5, 2021
Study Start
January 26, 2021
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
July 3, 2024
Record last verified: 2024-07